Citation Impact
Citing Papers
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
C-terminal region of activation-induced cytidine deaminase (AID) is required for efficient class switch recombination and gene conversion
2014 StandoutNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
A new taxonomy for describing and defining adherence to medications
2012 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Patient adherence and persistence with oral anticancer treatment
2009
From traditional Chinese medicine to rational cancer therapy
2007 Standout
CLINICAL STUDIES OF CAMPTOTHECIN AND DERIVATIVES
2003
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Optimising antiemetic therapy: what are the problems and how can they be overcome?
2005
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Mechanisms of Topoisomerase I Inhibition by Anticancer Drugs
1994 StandoutNobel
Lung Cancer
2008 Standout
Oral outpatient chemotherapy medication errors in children with acute lymphoblastic leukemia
2006
Thymoquinone: Potential cure for inflammatory disorders and cancer
2011 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines
2015 StandoutNobel
Acute Kidney Injury in Patients with Cancer
2017
Ondansetron
2001
Contingency planning for electronic health record-based care continuity: A survey of recommended practices
2014 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Acute kidney injury
2019 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Navigation in the electronic health record: A review of the safety and usability literature
2017 Standout
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
2002
Clinical applications of the camptothecins
1998
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics
2019
Oxidative Stress in Cancer
2020 Standout
Cisplatin Overdose
2009
Topoisomerase I inhibitors: Review and update
1997
Cisplatin: The first metal based anticancer drug
2019 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Human factors systems approach to healthcare quality and patient safety
2013 Standout
Camptothecin: A promising antiretroviral drug
1996
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Repair of and checkpoint response to topoisomerase I-mediated DNA damage
2003
Camptothecins
2002
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Health IT and Patient Safety: Building Safer Systems for Better Care
2012
Molecular Modeling Studies of the DNA−Topoisomerase I Ternary Cleavable Complex with Camptothecin
1998 StandoutNobel
Natural and Designed Proteins Inspired by Extremotolerant Organisms Can Form Condensates and Attenuate Apoptosis in Human Cells
2022 StandoutNobel
Plant Products as Antimicrobial Agents
1999 Standout
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
2006
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Mathematics – Key Technology for the Future
2008 Standout
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
2017
Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors
2006
APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination
2014 StandoutNobel
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Transcription-Dependent Degradation of Topoisomerase I-DNA Covalent Complexes
2003
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Works of Sylvia Bartel being referenced
Oral chemotherapy safety practices at US cancer centres: questionnaire survey
2007
Lack of Efficacy of Streptozocin and Doxorubicin in Patients With Advanced Pancreatic Endocrine Tumors
2004
Medication safety in the ambulatory chemotherapy setting
2005
Stratified Administration of Serotonin 5-HT3 Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis
2000
Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia
2013
Denosumab in hypercalcemia of malignancy: A case series
2014
A phase I and pharmacokinetic study of a new camptothecin derivative, 9-aminocamptothecin.
1995